Abstract

Perforin-2 (MPEG1) is a pore-forming, antibacterial protein with broad-spectrum activity. Perforin-2 is expressed constitutively in phagocytes and inducibly in parenchymal, tissue-forming cells. In vitro, Perforin-2 prevents the intracellular replication and proliferation of bacterial pathogens in these cells. Perforin-2 knockout mice are unable to control the systemic dissemination of methicillin-resistant Staphylococcus aureus (MRSA) or Salmonella typhimurium and perish shortly after epicutaneous or orogastric infection respectively. In contrast, Perforin-2-sufficient littermates clear the infection. Perforin-2 is a transmembrane protein of cytosolic vesicles -derived from multiple organelles- that translocate to and fuse with bacterium containing vesicles. Subsequently, Perforin-2 polymerizes and forms large clusters of 100Å pores in the bacterial surface with Perforin-2 cleavage products present in bacteria. Perforin-2 is also required for the bactericidal activity of reactive oxygen and nitrogen species and hydrolytic enzymes. Perforin-2 constitutes a novel and apparently essential bactericidal effector molecule of the innate immune system.

Article and author information

Author details

  1. Ryan M McCormack

    Department of Microbiology and Immunology, Miller School of Medicine, University of Miami, Miami, United States
    Competing interests
    Ryan M McCormack, This author is an inventor of patents used in the study and stand to gain royalties from future commercialization..
  2. Lesley R de Armas

    Department of Microbiology and Immunology, Miller School of Medicine, University of Miami, Miami, United States
    Competing interests
    Lesley R de Armas, This author is an inventor of patents used in the study and stand to gain royalties from future commercialization..
  3. Motoaki Shiratsuchi

    Department of Microbiology and Immunology, Miller School of Medicine, University of Miami, Miami, United States
    Competing interests
    No competing interests declared.
  4. Desiree G Fiorentino

    Department of Microbiology and Immunology, Miller School of Medicine, University of Miami, Miami, United States
    Competing interests
    No competing interests declared.
  5. Melissa L Olsson

    Department of Microbiology and Immunology, Miller School of Medicine, University of Miami, Miami, United States
    Competing interests
    No competing interests declared.
  6. Mathias G Lichtenheld

    Department of Microbiology and Immunology, Miller School of Medicine, University of Miami, Miami, United States
    Competing interests
    No competing interests declared.
  7. Alejo Morales

    Department of Microbiology and Immunology, Miller School of Medicine, University of Miami, Miami, United States
    Competing interests
    No competing interests declared.
  8. Kirill Lyapichev

    Department of Microbiology and Immunology, Miller School of Medicine, University of Miami, Miami, United States
    Competing interests
    Kirill Lyapichev, This author is an inventor of patents used in the study and stand to gain royalties from future commercialization..
  9. Louis E Gonzalez

    Department of Microbiology and Immunology, Miller School of Medicine, University of Miami, Miami, United States
    Competing interests
    No competing interests declared.
  10. Natasa Strbo

    Department of Microbiology and Immunology, Miller School of Medicine, University of Miami, Miami, United States
    Competing interests
    No competing interests declared.
  11. Neelima Sukumar

    Department of Microbiology and Immunology, College of Veterinary Medicine, Cornell University, Ithaca, United States
    Competing interests
    No competing interests declared.
  12. Olivera Stojadinovic

    Wound Healing and Regenerative Medicine Research Program, Department of Dermatology and Cutaneous Surgery, Miller School of Medicine, University of Miami, Miami, United States
    Competing interests
    No competing interests declared.
  13. Gregory V Plano

    Department of Microbiology and Immunology, Miller School of Medicine, University of Miami, Miami, United States
    Competing interests
    No competing interests declared.
  14. George P Munson

    Department of Microbiology and Immunology, Miller School of Medicine, University of Miami, Miami, United States
    Competing interests
    No competing interests declared.
  15. Marjana Tomic-Canic

    Wound Healing and Regenerative Medicine Research Program, Department of Dermatology and Cutaneous Surgery, Miller School of Medicine, University of Miami, Miami, United States
    Competing interests
    No competing interests declared.
  16. Robert S Kirsner

    Wound Healing and Regenerative Medicine Research Program, Department of Dermatology and Cutaneous Surgery, Miller School of Medicine, University of Miami, Miami, United States
    Competing interests
    No competing interests declared.
  17. David G Russell

    Department of Microbiology and Immunology, College of Veterinary Medicine, Cornell University, Ithaca, United States
    Competing interests
    No competing interests declared.
  18. Eckhard R Podack

    Microbiology and Immunology, U. Miami, School of Medicine, Miami, United States
    For correspondence
    epodack@miami.edu
    Competing interests
    Eckhard R Podack, This author is an inventor of patents used in the study and stand to gain royalties from future commercialization..

Reviewing Editor

  1. Pascale Cossart, Institut Pasteur, France

Ethics

Animal experimentation: This study was performed in strict accordance with the recommendations in the Guide for the Care and Use of Laboratory Animals of the National Institutes of Health. All of the animals were handled according to approved institutional animal care and use committee (IACUC) protocols (#13-233 and #12-259) of the University of Miami Miller School of Medicine.

Version history

  1. Received: January 15, 2015
  2. Accepted: September 23, 2015
  3. Accepted Manuscript published: September 24, 2015 (version 1)
  4. Version of Record published: October 30, 2015 (version 2)

Copyright

© 2015, McCormack et al.

This article is distributed under the terms of the Creative Commons Attribution License permitting unrestricted use and redistribution provided that the original author and source are credited.

Metrics

  • 4,805
    views
  • 884
    downloads
  • 64
    citations

Views, downloads and citations are aggregated across all versions of this paper published by eLife.

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Open citations (links to open the citations from this article in various online reference manager services)

Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)

  1. Ryan M McCormack
  2. Lesley R de Armas
  3. Motoaki Shiratsuchi
  4. Desiree G Fiorentino
  5. Melissa L Olsson
  6. Mathias G Lichtenheld
  7. Alejo Morales
  8. Kirill Lyapichev
  9. Louis E Gonzalez
  10. Natasa Strbo
  11. Neelima Sukumar
  12. Olivera Stojadinovic
  13. Gregory V Plano
  14. George P Munson
  15. Marjana Tomic-Canic
  16. Robert S Kirsner
  17. David G Russell
  18. Eckhard R Podack
(2015)
Perforin-2 is essential for intracellular defense of parenchymal cells and phagocytes against pathogenic bacteria
eLife 4:e06508.
https://doi.org/10.7554/eLife.06508

Share this article

https://doi.org/10.7554/eLife.06508

Further reading

    1. Chromosomes and Gene Expression
    2. Immunology and Inflammation
    Rajan M Thomas, Matthew C Pahl ... Andrew D Wells
    Research Article

    Ikaros is a transcriptional factor required for conventional T cell development, differentiation, and anergy. While the related factors Helios and Eos have defined roles in regulatory T cells (Treg), a role for Ikaros has not been established. To determine the function of Ikaros in the Treg lineage, we generated mice with Treg-specific deletion of the Ikaros gene (Ikzf1). We find that Ikaros cooperates with Foxp3 to establish a major portion of the Treg epigenome and transcriptome. Ikaros-deficient Treg exhibit Th1-like gene expression with abnormal production of IL-2, IFNg, TNFa, and factors involved in Wnt and Notch signaling. While Ikzf1-Treg-cko mice do not develop spontaneous autoimmunity, Ikaros-deficient Treg are unable to control conventional T cell-mediated immune pathology in response to TCR and inflammatory stimuli in models of IBD and organ transplantation. These studies establish Ikaros as a core factor required in Treg for tolerance and the control of inflammatory immune responses.

    1. Evolutionary Biology
    2. Immunology and Inflammation
    Mark S Lee, Peter J Tuohy ... Michael S Kuhns
    Research Advance

    CD4+ T cell activation is driven by five-module receptor complexes. The T cell receptor (TCR) is the receptor module that binds composite surfaces of peptide antigens embedded within MHCII molecules (pMHCII). It associates with three signaling modules (CD3γε, CD3δε, and CD3ζζ) to form TCR-CD3 complexes. CD4 is the coreceptor module. It reciprocally associates with TCR-CD3-pMHCII assemblies on the outside of a CD4+ T cells and with the Src kinase, LCK, on the inside. Previously, we reported that the CD4 transmembrane GGXXG and cytoplasmic juxtamembrane (C/F)CV+C motifs found in eutherian (placental mammal) CD4 have constituent residues that evolved under purifying selection (Lee et al., 2022). Expressing mutants of these motifs together in T cell hybridomas increased CD4-LCK association but reduced CD3ζ, ZAP70, and PLCγ1 phosphorylation levels, as well as IL-2 production, in response to agonist pMHCII. Because these mutants preferentially localized CD4-LCK pairs to non-raft membrane fractions, one explanation for our results was that they impaired proximal signaling by sequestering LCK away from TCR-CD3. An alternative hypothesis is that the mutations directly impacted signaling because the motifs normally play an LCK-independent role in signaling. The goal of this study was to discriminate between these possibilities. Using T cell hybridomas, our results indicate that: intracellular CD4-LCK interactions are not necessary for pMHCII-specific signal initiation; the GGXXG and (C/F)CV+C motifs are key determinants of CD4-mediated pMHCII-specific signal amplification; the GGXXG and (C/F)CV+C motifs exert their functions independently of direct CD4-LCK association. These data provide a mechanistic explanation for why residues within these motifs are under purifying selection in jawed vertebrates. The results are also important to consider for biomimetic engineering of synthetic receptors.